“Hepatitis b”的搜索结果，显示 371-380 项，共有 9257 项
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
A Study to Evaluate Outpatient Blinatumomab in Subjects with Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL). Jacksonville ...
AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL ... B-cell non-Hodgkin lymphoma (NHL) who have received at least two prior ...
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz ...
... B cell malignancies by engineering T cells to recognize B cell specific tumor markers; however, attempts to treat solid tumors with CAR T-cells have ...
Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma. Rochester, Minn., Scottsdale/Phoenix ...
皮肤B 细胞淋巴瘤是一种罕见癌症，始发于白细胞。这种癌症会侵袭皮肤。皮肤B 细胞淋巴瘤始发于一种称为B 细胞的抗菌白细胞。这些细胞又称为B 淋巴细胞。
The purpose of this study is to evaluate the safety and tolerability of STP938 as a single agent in adult subjects with R/R B-cell and T-cell lymphomas.
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。